-
A Peek Into The Markets: U.S. Stock Futures Rise On Final Trading Day Of 2016
Friday, December 30, 2016 - 8:27am | 422Read More...Pre-open movers U.S. stock futures traded higher in early pre-market trade. The Chicago PMI for December is schedule for release at 9:45 a.m. ET. Futures for the Dow Jones Industrial Average climbed 28 points to 19,787.00, while the Standard & Poor’s 500 index futures rose 4 points...
-
Wall Street Analysts React To Illumina's Concerning Outlook, Ensuing 25% Drop In Shares
Tuesday, October 11, 2016 - 4:57pm | 642Read More...Illumina, Inc. (NASDAQ: ILMN)'s warning issued Monday after the close created quite a stir in the markets, with traders punishing the stock with a massive selloff. The stock was down over 25 percent to its lowest level in over three months. The news of the potential shortfall in the third-quarter...
-
Sarepta Shares Continue Rally As Analysts Flip To Positive
Tuesday, September 20, 2016 - 3:04pm | 426Read More...The craze for Sarepta Therapeutics Inc (NASDAQ: SRPT) shares continued into its second day, gaining about 15 percent on Tuesday. The stock nearly doubled from the $28.15 recorded on September 16. Two catalysts likely responsible for this rally include the FDA approval for the company's Duchenne...
-
Biotech's 'New Sweetheart': Janney Upgrades Sarepta To Buy
Monday, September 19, 2016 - 11:00am | 214Read More...Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) soared higher by 80 percent Monday and hit a new 52-week high of $52.30 after the U.S. Food and Drug Administration granted the company with an accelerated FDA approval for its Eteplirsen drug. Related Link: Sarepta's Eteplirsen Receives...
-
Analysts Give Healthcare Sector A Clean Bill Of Health
Friday, June 17, 2016 - 9:33am | 255Read More...Here’s a summary of recent analyst coverage on Healthcare: Bernstein on HCA Holdings Inc (NYSE: HCA): Market Perform, $88 Price Target Bernstein on UnitedHealth Group Inc (NYSE: UNH): Outperform, $142 Price Target Morgan Stanley on Cepheid (NASDAQ: CPHD): Equal Weight, $30 Price Target...
-
Janney Capital Initiates New Jersey Resources At Buy
Thursday, June 18, 2015 - 8:26am | 70Read More...Analysts at Janney Capital initiated coverage on New Jersey Resources Corp (NYSE: NJR) with a Buy rating. The target price for New Jersey Resources is set to $36. New Jersey Resources shares have dropped 1.93 percent over the past 52 weeks, while the S&P 500 index has surged 7.19 percent in the...
-
Janney Capital Initiates Community Healthcare At Buy
Monday, June 15, 2015 - 9:51am | 32Read More...Janney Capital initiated coverage on Community Healthcare Trust Inc (NYSE: CHCT) with a Buy rating. Community Healthcare shares closed at $19.04 on Friday.
-
Janney Capital Downgrades Boulder Brands To Neutral
Thursday, June 11, 2015 - 8:34am | 53Read More...Janney Capital downgraded Boulder Brands Inc (NASDAQ: BDBD) from Buy to Neutral. Boulder Brands shares have dropped 52.11 percent over the past 52 weeks, while the S&P 500 index has surged 9.07 percent in the same period. Boulder Brands' shares fell 0.14 percent to $6.90 in after-hours trading.
-
Janney Capital Initiates Universal Health Services With Neutral
Wednesday, June 10, 2015 - 8:19am | 68Read More...Janney Capital initiated coverage on Universal Health Services, Inc. (NYSE: UHS) with a Neutral rating. The target price for Universal Health Services is set to $141. Universal Health Services shares have gained 37.37 percent over the past 52 weeks, while the S&P 500 index has surged 7.01...
-
Janney Capital Initiates B&G Foods With Neutral
Tuesday, June 2, 2015 - 9:50am | 67Read More...Analysts at Janney Capital initiated coverage on B&G Foods, Inc. (NYSE: BGS) with a Neutral rating. The target price for B&G Foods is set to $32. B&G Foods shares have dropped 8.99 percent over the past 52 weeks, while the S&P 500 index has surged 9.74 percent in the same period. B...
-
Janney Capital Downgrades Abercrombie & Fitch To Sell
Friday, May 29, 2015 - 8:41am | 64Read More...Analysts at Janney Capital downgraded Abercrombie & Fitch Co. (NYSE: ANF) from Neutral to Sell. The price target for Abercrombie & Fitch is set to $15. Abercrombie & Fitch shares have dropped 39.96 percent over the past 52 weeks, while the S&P 500 index has surged 10.46 percent in...
-
Janney Capital Initiates Aldeyra Therapeutics With Buy
Wednesday, May 27, 2015 - 8:57am | 64Read More...Janney Capital initiated coverage on Aldeyra Therapeutics Inc (NASDAQ: ALDX) with a Buy rating. The target price for Aldeyra Therapeutics is set to $13. Aldeyra Therapeutics shares have gained 11.53 percent over the past 52 weeks, while the S&P 500 index has surged 10.18 percent in the same...
-
Janney Capital Initiates Advaxis At Buy
Friday, May 15, 2015 - 8:15am | 62Read More...Analysts at Janney Capital initiated coverage on Advaxis, Inc. (NASDAQ: ADXS) with a Buy rating. The target price for Advaxis is set to $26. Advaxis shares have gained 615.85 percent over the past 52 weeks, while the S&P 500 index has surged 12.95 percent in the same period. Advaxis shares rose...
-
Janney Capital Initiates Spectra Energy Partners With Buy
Thursday, May 14, 2015 - 8:58am | 70Read More...Analysts at Janney Capital initiated coverage on Spectra Energy Partners, LP (NYSE: SEP) with a Buy rating. The target price for Spectra Energy Partners is set to $43. Spectra Energy Partners shares have dropped 1.07 percent over the past 52 weeks, while the S&P 500 index has surged 11.12...
-
Janney Capital Initiates OFS Capital At Neutral
Thursday, May 7, 2015 - 10:04am | 55Read More...Janney Capital initiated coverage on OFS Capital Corp (NASDAQ: OFS) with a Neutral rating. OFS Capital shares have dropped 1.93 percent over the past 52 weeks, while the S&P 500 index has surged 10.90 percent in the same period. OFS Capital shares fell 1.85 percent to close at $12.22 yesterday.
